Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a + ribavirin + metformin vs Peginterferon alfa-2a + ribavirin in chronic hepatitis C with insulin resistance
2005-003853-29Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Nov 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hepatitis C virus infection and insulin resistance (IR) comparing Peginterferon alfa-2a + ribavirin + metformin with Peginterferon alfa-2a + ribavirin (2 arms). Started Nov 2007; status: active.
02
Drugs
metforminpeginterferon alfa-2aribavirin
03
Conditions
hepatitis C virus infectioninsulin resistance (IR)
Beyond the preview
Go deeper on 2005-003853-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003853-29.